As on Wednesday, Cellectis ADR (NASDAQ: CLLS) got off with the flyer as it spiked 12.57% to $4.3, before settling in for the price of $3.82 at the close. Taking a more long-term approach, CLLS posted a 52-week range of $1.10-$3.83.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 29.97%. Meanwhile, its Annual Earning per share during the time was 29.97%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -113.80%. This publicly-traded company’s shares outstanding now amounts to $100.33 million, simultaneously with a float of $61.80 million. The organization now has a market capitalization sitting at $309.99 million. At the time of writing, stock’s 50-day Moving Average stood at $2.97, while the 200-day Moving Average is $1.89.
Cellectis ADR (CLLS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Cellectis ADR’s current insider ownership accounts for 14.28%, in contrast to 16.36% institutional ownership.
Cellectis ADR (CLLS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Cellectis ADR’s EPS decrease for this current 12-month fiscal period is -113.80% and is forecasted to reach -0.97 in the upcoming year.
Cellectis ADR (NASDAQ: CLLS) Trading Performance Indicators
Let’s observe the current performance indicators for Cellectis ADR (CLLS). It’s Quick Ratio in the last reported quarter now stands at 1.38. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.49.
In the same vein, CLLS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.57, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.97 at the market close of one year from today.
Technical Analysis of Cellectis ADR (CLLS)
Through scrutinizing the latest numbers posted by the [Cellectis ADR, CLLS], it can be observed that its last 5-days Average volume of 0.2 million was lower the volume of 0.21 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 93.10% While, its Average True Range was 78.19.
Raw Stochastic average of Cellectis ADR (CLLS) in the period of the previous 100 days is set at 91.14%, which indicates a major rise in contrast to 86.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.27 that was higher than 0.17 volatility it exhibited in the past 100-days period.
